‘Gender diversity and corporate boards’— Pharma leads the way!
Debabrat Mishra, Director, Hay Group India and Sudakshina Tyagi, Senior Consultant, Hay Group India elaborate on the need for more…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA raises concerns over Lupin’s plant at Pithampur
FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant
Lupin and Celon in agreement
Lupin and Celon Pharma have entered into a definitive agreement under which the companies will jointly develop fluticasone/…
Zydus completes phase I studies for its oral HIF inhibitor
The multiple dosing studies are expected to be completed by Q2 2015
Intas Pharmaceuticals launches biosimilar in Europe
The product has recently been introduced under the brand Accofil
Elder Pharma launches ‘Solo’ inhalers
Forays into the Rs 800-crore nasal inhaler segment
Glenmark gets US approval for Ashlyna extended cycle oral contraceptive tablets
The company plans to commence shipping of Ashlyna immediately
Cipla wins $ 189 m global tender
Cipla has been awarded US $188.95 million of Global Fund ARV tender
Mylan signs exclusive agreement with Gilead Sciences
Under the agreement Mylan will distribute Sovaldi and Harvoni in India
IPM clocks Rs 7294 crores revenue in January 2015
31 corporates have shown growth more than 10 per cent amongst the top 50